This paper is in the following e-collection/theme issue:

Consumer & Patient Education and Shared-Decision Making (679) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (156) Pharmacovigilance (134)

Published on in Vol 25 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/40616, first published .
Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study

Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study

Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study

Authors of this article:

Peter Johannes Schulz1, 2, 3 Author Orcid Image ;   Francesca Crosignani1 Author Orcid Image ;   Serena Petrocchi4 Author Orcid Image
Article Authors Cited by (1) Tweetations (3) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.